Characterization of Corticobulbar Pharyngeal Neurophysiology in Dysphagic Patients With Parkinson's Disease

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 12, 2014, Pages 2037-2045.e4

  Michou, Emilia ^a   Hamdy, Shaheen ^a   Harris, Mary ^a   Vania, Adil ^a   Dick, Jeremy ^b   Kellett, Mark ^b   Rothwell, John ^c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Brain; Compensation; Nervous System; Neurodegeneration

Indexed keywords

LEVODOPA; ANTIPARKINSON AGENT;

ADULT; AGED; ARTICLE; BRAIN STEM; CLINICAL ARTICLE; CORTICOBULBAR PHARYNGEAL; DOPAMINERGIC SYSTEM; DYSPHAGIA; FEMALE; HUMAN; INHIBITION KINETICS; MALE; NEUROPHYSIOLOGY; PARKINSON DISEASE; PHARYNGEAL MUSCLE; PHARYNX; QUALITATIVE ANALYSIS; QUALITY OF LIFE; QUESTIONNAIRE; SWALLOWING; TRANSCRANIAL MAGNETIC STIMULATION; TRIGEMINAL NERVE; VERY ELDERLY; COMPLICATION; FLUOROSCOPY; MIDDLE AGED; PATHOPHYSIOLOGY; PYRAMIDAL TRACT; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; DEGLUTITION DISORDERS; FEMALE; FLUOROSCOPY; GREAT BRITAIN; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; PYRAMIDAL TRACTS; SURVEYS AND QUESTIONNAIRES; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84918823220     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.03.020     Document Type: Article

References (33)

1. Kalf J.G., de Swart B.J., Bloem B.R., et al. Prevalence of oropharyngeal dysphagia in Parkinson's disease: a meta-analysis. Parkinsonism Relat Disord 2012, 18:311-315.
2. Beyer M.K., Herlofson K., Arsland D., et al. Causes of death in a community based study of Parkinson's disease. Acta Neurol Scand 2001, 103:7-11.
3. Michou E., Hamdy S. Dysphagia in Parkinson's disease: a therapeutic challenge?. Expert Rev Neurother 2010, 10:875-878.
4. Leow L., Huckabee M.-L., Anderson T., et al. The impact of dysphagia on quality of life in ageing and Parkinson's disease as measured by the swallowing quality of life (SWAL-QOL) questionnaire. Dysphagia 2010, 25:216-220.
5. Plowman-Prine E.K., Sapienza C.M., Okun M.S., et al. The relationship between quality of life and swallowing in Parkinson's disease. Mov Disord 2009, 24:1352-1358.
6. Halliday G.M., McCann H. The progression of pathology in Parkinson's disease. Ann N Y Acad Sci 2010, 1184:188-195.
7. Bartels A.L., Leenders K.L. Parkinson's disease: the syndrome, the pathogenesis and pathophysiology. Cortex 2009, 45:915-921.
8. Fleming S.M., Schallert T., Ciucci M.R. Cranial and related sensorimotor impairments in rodent models of Parkinson's disease. Behav Brain Res 2012, 231:317-322.
9. Mu L., Sobotka S., Chen J., et al. Altered pharyngeal muscles in Parkinson disease. JNeuropathol Exp Neurol 2012, 71:520-530.
10. Mu L., Sobotka S., Chen J., et al. Alpha-synuclein pathology and axonal degeneration of the peripheral motor nerves innervating pharyngeal muscles in Parkinson disease. JNeuropathol Exp Neurol 2013, 72:119-129.
11. Menezes C., Melo A. Does levodopa improve swallowing dysfunction in Parkinson's disease patients?. JClin Pharm Ther 2009, 34:673-676.
12. Lim A., Leow L., Huckabee M.L., et al. Apilot study of respiration and swallowing integration in Parkinson's disease: "on" and "off" levodopa. Dysphagia 2008, 23:76-81.
13. Suntrup S., Teismann I., Bejer J., et al. Evidence for adaptive cortical changes in swallowing in Parkinson's disease. Brain 2013, 136:726-738.
14. Hoehn M.M., Yahr M.D. Parkinsonism. Onset progression and mortality. Neurology 1967, 17:427.
15. Manor Y., Giladi N., Cohen A., et al. Validation of a swallowing disturbance questionnaire for detecting dysphagia in patients with Parkinson's disease. Mov Disord 2007, 22:1917-1921.
16. McHorney C.A., Robbins J., Lomax K., et al. The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults: III. Documentation of reliability and validity. Dysphagia 2002, 17:97-114.
17. Hamdy S., Aziz Q., Rothwell J.C., et al. Cranial nerve modulation of human cortical swallowing motor pathways. Am J Physiol 1997, 272:G802-G808.
18. Hamdy S., Aziz Q., Rothwell J.C., et al. The cortical topography of human swallowing musculature in health and disease. Nat Med 1996, 2:1217-1224.
19. Snaith R.P., Zigmond A.S. Hospital Anxiety and Depression Scale (HADS). Handbook of psychiatric measures 2000, 547-548. American Psychiatric Association, Washington, DC. A.J. Rush (Ed.).
20. Jasper H.H. The 10-20 electrode system of the International Federation. Electroencephalogr Clin Neurophysiol 1958, 10:371-375.
21. Wassermann E.M., McShane L.M., Hallett M., et al. Noninvasive mapping of muscle representations in human motor cortex. Electroencephalogr Clin Neurophysiol 1992, 85:1-8.
22. Rosenbek J., Robbins J.A., Roecker E.B., et al. Apenetration-aspiration scale. Dysphagia 1996, 11:93-98.
23. Baijens L.W., Speyer R., Passos V.L., et al. Swallowing in Parkinson patients versus healthy controls: reliability of measurements in videofluoroscopy. Gastroenterol Res Pract 2011, 2011:380682.
24. Sethi K. Levodopa unresponsive symptoms in Parkinson disease. Mov Disord 2008, 23(Suppl 3):S521-S533.
25. Braak H., Del Tredici K., Bratzke H., et al. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). JNeurol 2002, 249(Suppl 3). III/1-5.
26. Braak H., Rub U., Gai W.P., et al. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. JNeural Transm 2003, 110:517-536.
27. Hunter P.C., Crameri J., Austin S., et al. Response of parkinsonian swallowing dysfunction to dopaminergic stimulation. JNeurol Neurosurg Psychiatry 1997, 63:579-583.
28. Monte F.S., da Silva-Júnior F.P., Braga-Neto P., et al. Swallowing abnormalities and dyskinesia in Parkinson's disease. Mov Disord 2005, 20:457-462.
29. Lefaucheur J.P. Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation. Clin Neurophysiol 2005, 116:244-253.
30. Kessler J.P., Jean A. Inhibitory influence of monoamines and brainstem monoaminergic regions on the medullary swallowing reflex. Neurosci Lett 1986, 65:41-46.
31. Bieger D., Giles S.A., Hockman C.H. Dopaminergic influences on swallowing. Neuropharmacology 1977, 16:245-252.
32. Hamdy S., Aziz Q., Rothwell J.C., et al. Explaining oropharyngeal dysphagia after unilateral hemispheric stroke. Lancet 1997, 350:686-692.
33. Ertekin C., Eryaşar G., Gürgör N., et al. Orbicularis oculi muscle activation during swallowing in humans. Exp Brain Res 2013, 224:79-91.